BioWorld MedTech

Dec. 14, 2016

View Archived Issues

FDA gives green light to Lumendi's new platform to treat colonic lesions

With an eye toward promoting minimally invasive procedures and treating colorectal disease within a patient's intestine, Westport, Conn.-based Lumendi LLC has scored a win at the U.S. FDA with its new device. Read More

Chinese patents continue torrid pace, med-tech is a key area of progress

Read More

Gone fishing: Blackfynn's data platform likely lure for partners in neurology

Read More

Varian revs up for public spin off of imaging business

Read More

FDA strikes more measured tone in emerging signals final

Read More

Other news to note

Read More

Appointments and advancements

Read More

Product briefs

Read More

Daily M&A

Read More

MDD's Oncology Extra

Read More